Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

GameStop’s Resilience Is Still Amazing

By Will Ashworth, InvestorPlace Contributor
GameStop continues to trade well above$200. I remain amazed at the resilience of GME stock. Can the shares continue to hang tough?  

Avoid Canoo Stock as Short-Sellers Pile on

By Chris Lau, InvestorPlace Contributor
Canoo's short float is so high that the bearish bets against this EV firm are very likely to pay off as GOEV stock falls further.

Hold Off On TPG Pace Beneficial Finance as Deal Risk Persists

By David Moadel, InvestorPlace Contributor
Even promising SPAC deals can fall through. This is a risk TPGY stock holders must deal with - or they can just bail and avoid this problem.

7 Former Pandemic Stocks to Buy That Are No Longer Running Hot

By Josh Enomoto, InvestorPlace Contributor
The pandemic bolstered many stocks to buy. But with cases fading, this narrative is now questionable. These seven stocks require caution.

MicroVision Has Potential but Is Hardly Worth Its Current Price

By Muslim Farooque, InvestorPlace Contributor
MVIS stock is trading at parabolic levels which are hardly in line with its weak fundementals and future growth prospects

Blackberry Stock Is a Dog and Has Been for Quite Some Time

By Dana Blankenhorn, InvestorPlace Contributor
Blackberry's latest move upward died when shorts piled in. It's a no-growth money-loser.

The Videogame Industry Has Passed GameStop By

By Muslim Farooque, InvestorPlace Contributor
The video gaming industry has undergone some massive changes off-late but GME stock has failed to differentiate its services

With a Stumbling Track Record, All Signs Say Stay Away from Novavax

By Thomas Niel, InvestorPlace Contributor
Overseas Covid-19 vaccine deals could save the day, but it's hard to imagine the dwindling prospects of NVAX stock turning on a dime.

Foxconn Deal May Signal Trouble for Fisker

By Alex Sirois, InvestorPlace Contributor
Fisker's Ocean EV can still make waves on the market, but a change of manufacturer doesn't bode well for their second vehicle or FSR stock.

Lucid Motors Stock May Not Have Much Upside, Given Its Implied Valuation

By Mark R. Hake, CFA
CCIV / Lucid Stock may not have as much upside given its implied valuation. CCIV stock could fall to about $13.20 after the merger closes, based on a comp with Tesla.

7 Falling-Knife Stocks You Don’t Want to Catch

By Josh Enomoto, InvestorPlace Contributor
With the market’s rumblings producing plenty of red ink, investors should be careful about not buying into a falling knife.

GameStop Stock Is Still Too High, Even If It Posts Solid Q1 Results

By Mark R. Hake, CFA
Expect to see good Q1 numbers at GameStop, but GME stock is still too high. Expect to see it fall at least 20% given its prospects for lower margins.

Lemonade Turned Out to Just Be a Lemon

By Dana Blankenhorn, InvestorPlace Contributor
Lemonade has a good idea, using devices and the cloud to cut the costs of consumer insurance. But the rest of the industry is already doing that.

Don’t Expect Huge Fireworks from Rocket Companies Stock As Rates Rise

By Mark R. Hake, CFA
Don't expect huge fireworks from Rocket Companies stock as rates rise. Rocket stock is likely to fall to $11.00 or 35% below today’s price as rates rise with lower mortgage volumes.

Avoid AMC Entertainment As CEO Relishes Meme Lord Status

By David Moadel, InvestorPlace Contributor
AMC prices don't match first-quarter performance and the CEO encourages trading mania. Sensible investors should opt to not own AMC stock.

The Bullish Narrative on Walmart Relies Too Much on Stimulus

By Louis Navellier and the InvestorPlace Research Staff
The pandemic panic-buying of basic goods is over. WMT stock holders may count on stimulus funds to boost sales, but that won't last forever.

Take Profits If You Own Ocugen Stock, but Now’s Not the Time to Buy

By Tezcan Gecgil, InvestorPlace Contributor
As Ocugen has a long way to go to get approval from the FDA and commercialize Covaxine, OCGN stock will not likely to reach new highs soon.

It’s Time for Long-Term Investors to Bail on Palantir Stock

By Larry Ramer, InvestorPlace Contributor
Palantir is very reliant on the shares of PLTR stock to pay its bills and make its ends meet. That situation is not positive for longer-term investors.

Churchill Capital a Clear Sell As SPAC Mania Subsides

By Dana Blankenhorn, InvestorPlace Contributor
The Securities and Exchange Commission has begun cracking down on the shenanigans that made deals like CCIV's merger with Lucid Motors attractive.
Load More Articles